Bio21 Molecular Science & Biotechnology Institute

New approaches for antibiotic and anti-inflammatory sulfa-drug allergies

Researchers have discovered a mechanism that activates part of the body’s immune system through a class of molecules that structurally resemble sulfa-drugs.
Professor Paul Donnelly and the highly successful public listing of the company he co-founded.

Congratulations to Professor Paul Donnelly on the highly successful public listing of the company he co-founded, Clarity Radiopharmaceuticals
Pursuit: Starving the bacterium that causes pneumonia

Over a decade ago, Professor Christopher McDevitt, laboratory head at the Doherty Institute, and Associate Professor Maher forged a collaboration to pursue a clue that manganese was vital for the survival, metabolism and infectivity of S. pneumoniae.
Bio21’s Dr Stanley Xie receives the Federation of Asian and Oceanian Biochemists and Molecular Biologists (FAOBMB) Young Scientist Award

Bio21’s Dr Stanley Xie, Department of Biochemistry and Pharmacology, received the Federation of Asian and Oceanian Biochemists and Molecular Biologists (FAOBMB) Young Scientist Award.
Dr David Stroud awarded prestigious NHMRC Investigator Grant

Congratulations to Dr David Stroud on the award of a prestigious NHMRC Investigator Grant

Search form

Home